Table 8.
[68Ga]Ga-PSMA-11 PET/CT in 89 patients initially treated with radical prostatectomy (Ga-RP): subgroups of patients according to the number of PSMA-positive lesions categorized by pre-scan threshold 1.84 ng/mL.
| PSA Range (ng/mL) | Overall Positivity | p/r-Value | Oligo-Metastatic | Multi-Metastatic | p/r-Value | |
| <1.84 (42) | 33 (78.6%) | 10 (23.8%) | 12 (28.6%) | |||
| ≥1.84 (47) | 43 (91.5%) | 5 (10.6%) | 32 (68.1%) | |||
| Total (89) | 76 (85.4%) |
p = 0.085 r = 0.183 |
15 (16.9%) | 44 (49.4%) |
p = 0.001 r = 0.366 |
|
| PSA Range (ng/mL) | Local Recurrence | p/r-Value | Local Metastases | Distant Metastases | Local + Distant Metastases | p/r-Value |
| <1.84 (42) | 14 (33.3%) | 10 (23.8%) | 7 (16.7%) | 5 (11.9%) | ||
| ≥1.84 (47) | 13 (27.7%) | 9 (19.1%) | 11 (23.4%) | 17 (36.2%) | ||
| Total (89) | 27 (30.3%) |
p = 0.561 r = −0.062 |
19 (21.3%) | 18 (20.2%) | 22 (46.8%) |
p = 0.014 r = 0.344 |
Abbreviations: PSA, prostate-specific antigen; p-value < 0.05 is considered significant.